The partitions (AC n-hexane, IC n-hexane, and IC ethylacetate), and the AC n-hexane-ethylacetate fraction were obtained from our previous study [8 (link)]. The HPLC grade of methanol, acetonitrile, and phosphate buffer pH 7.4 were used as the mobile phase, whereas the stationary phase used C18 column. The MMP9 enzyme kit was obtained from BioVision and comprised lyophilized MMP9, FRET-based MMP9 substrate (Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg), MMP9 assay buffer, and NNGH inhibitor (N-isobutyl-N-(4-methoxyphenylsulfonyl)-glycyl hydroxamic acid) as its positive control. MDA-MB-231, MCF7, T47D, and 4T1 cells were obtained from Parasitology Laboratory, Medical Faculty, Gadjah Mada University), and cultured in Dulbecco’s Modified Eagle Media (DMEM) for MDA-MB-231, MCF7, and T47D, and RPMI-1640 medium containing 10% (v/v) fetal bovine serum (FBS) and 1% penicillin–streptomycin was used as the media for 4T1 (Life Technologies, Carlsbad, CA, USA) at 37 °C in a 5% CO2 humidified incubator. RNase was courtesy from Parasitology Laboratory, Medical Faculty, Gadjah Mada University and cultured in Dulbecco’s Modified Eagle Media (DMEM). Doxorubicin (DOX) and 3-(4,5-dimethylthiazol-zyl)-2,5-diphenyl tetrazolium bromide (MTT) were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Free full text: Click here